Celecoxib loses its anti‐inflammatory efficacy at high doses through activation of NF‐κB
- 29 May 2001
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 15 (9), 1622-1624
- https://doi.org/10.1096/fj.00-0716fje
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB 553/C6)
This publication has 38 references indexed in Scilit:
- Combinations for cancer preventionNature Medicine, 2000
- Activation of NF-.KAPPA.B Determines the Sensitivity of Human Colon Cancer Cells to TNF.ALPHA.-Induced Apoptosis.Biological & Pharmaceutical Bulletin, 2000
- Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparisonThe Lancet, 1999
- Kinetic basis for selective inhibition of cyclo-oxygenasesBiochemical Journal, 1999
- Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritisInflammation Research, 1998
- NF-κB: Ten Years AfterCell, 1996
- Activation of transcription factor NF‐κB in human synovial cells in response to tumor necrosis factor αArthritis & Rheumatism, 1996
- Serum and Glucocorticoid Regulation of Gene Transcription and Expression of the Prostaglandin H Synthase-1 and Prostaglandin H Synthase-2 IsozymesArchives of Biochemistry and Biophysics, 1993
- Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes.Proceedings of the National Academy of Sciences, 1993
- Analysis of nitrate, nitrite, and [15N]nitrate in biological fluidsAnalytical Biochemistry, 1982